Lupin has been exclusively marketing these brands in the Indian market since July 2021
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Jeet will be a trusted partner in cardiovascular care
Through this important initiative, Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in the Aptivate Champion Run
Valentas and Arnipin are indicated to reduce repeated hospitalization and the risk of cardiovascular death among adult patients with chronic mild to moderate heart failure
The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
The drug is priced at Rs 2000 for a course of 40 tablets
Subscribe To Our Newsletter & Stay Updated